Skip to main content
Premium Trial:

Request an Annual Quote

Reprocell Acquires BioServe, Reinnervate

NEW YORK (GenomeWeb) – Japanese stem cell products company Reprocell said today that it has purchased 3D cell culture firm Reinnervate and US genomics services firm BioServe.

Sedgefield, UK-based Reinnervate makes the Alvetex line of 3D cell culture products, which will be combined with Reprocell's induced pluripotent stem cells to produce next-generation tools for drug toxicity, neuroscience, and cancer research.

Beltsville, Md.-based BioServe operates a commercial biorepository, which supplies human tissues, serum, and DNA and RNA samples to researchers around the globe. It also provides a variety of genomic services including genotyping, DNA and RNA extraction, gene expression and allelic discrimination using real-time PCR, and molecular diagnostic testing out of its CLIA-certified facility.

Reprocell intends to use its access to the samples in BioServe's respository to generate a wide range of disease-related iPSC lines for use in human cell models.

Financial terms of the acquisitions were not disclosed.